Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowEli Lilly and Co. Chairman and CEO John Lechleiter is back to full-time work after undergoing surgery on May 13 for a dilated aorta. The Indianapolis-based drugmaker said both a company doctor and Lechleiter's personal physician have cleared the 59-year-old to return. Chief Financial Officer Derica Rice served as acting CEO for the Indianapolis-based drug company during Lechleiter's leave, and independent director Ellen Marram served as acting chairwoman.
Please enable JavaScript to view this content.